Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sana Biotechnology
Biotech
Sana stock price triples after allogeneic cell therapy data drop
The data “pave the way for a potentially transformative cure,” for the 1.7 million Americans with type 1 diabetes, Citi analysts wrote Jan. 8.
Gabrielle Masson
Jan 8, 2025 10:38am
Sana strips back cancer, CNS programs while warning of layoffs
Nov 5, 2024 7:05am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
Sana's engineered islet cells control glucose in diabetic monkey
Feb 15, 2024 2:55pm
Sana retreats from in vivo CAR-T delivery, lays off 29% of staff
Oct 11, 2023 5:00am
Sana tight-lipped on extent of latest round of layoffs
Sep 1, 2023 5:40am
